RushNet, Inc.
Other OTCRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- RushNet, Inc. (OTC Pink: RSHN) operates as a healthcare services company focused on laboratory diagnostic testing, management, and insurance billing, primarily through its subsidiary heliosDX, a national clinical reference laboratory, and Grandeza Healthcare, a billing and coding firm; core offerings encompass high-complexity urine drug testing, behavioral drug testing, allergy droplet cards, oral fluids testing, PCR panels for nail, wound, respiratory pathogen, STI, GI, and UTI conditions via lab partners, infectious disease services, and patient-centered billing protocols with in-house processing and easy online payments. The company, founded in 1997 and headquartered at 8465 Merchants Way, Suite 206, Jacksonville, Florida, serves physicians and patients across the United States with prompt 48-hour resulting, interactive sales and results portals, and streamlined shipping via Cardinal Health partnerships. Recent developments include debt restructuring to resume partner payments at 3% of monthly gross revenues with 1% interest, appointment of Michael A. Cunha as CEO and Chairman in 2024, a 79% reduction in authorized and fully diluted outstanding shares, cancellation of a proposed reverse split, and pursuit of revenue growth targets aiming for $50 million in three years amid expansions into blood toxicology, hormone testing, and wellness patches for retail via Amazon and its website.
RushNet Licensing Partner Royal Caridea Achieves the Fastest Shrimp Growth Rate in the Aquaculture Industry Reaching 42 Grams in 90 Days
RushNet Partners with Royal Caridea LLC Through an Exclusive Licensing Agreement to Revolutionize Sustainable Aquaculture
RushNet Names Arizona Businessman Michael Cunha as Chairman and Chief Executive Officer
RushNet Announces: A New Era for Digital Community Engagement
heliosDX Succumbs to Unprecedented Challenges in the Healthcare Market
heliosDX to Present at the Emerging Growth Conference on Wednesday October 27, 2021; Invites Institutional and Individual Investors
RushNet, Inc (RSHN) Subsidiary heliosDX Surpasses Major Financial Milestone, on Track with 2021 Stretch Target of $6 Million in Revenue
heliosDX to Remain as a Rushnet Subsidiary Along With Grandeza Healthcare
heliosDX Adds Artificial Intelligence to its Suite of Diagnostics Services and Solutions
heliosDX Announces Pursuit of TSX-V Listing and Roadmap Update
heliosDX Announces Director of Sales and Marketing
RushNet, Inc and heliosDX Announces Appointment of COO
heliosDX Announces First Board Member upon Split-Off of RushNet, Inc and RushNet Share Conversion
RushNet, Inc Closes the Acquisition of heliosDX which Brings Significant Revenues to the Company
RushNet, Inc with heliosDX Announces Roadmap Update, Dividend Enhancements, and Acquisition Update
RushNet Inc. to Close on Acquisition/Spinoff of HeliosDX and Reveals Future Plans
RushNet Inc. Cancellation of Proposed Reverse Split
heliosDX and RushNet Inc. Sign Binding Letter of Intent to Acquire Laboratory and Target Additional Laboratory Acquisitions
RushNet, Inc Reverse Merger and Roadmap Update